Funder: Alzheimer's Association
Due Dates: August 6, 2025 (LOI) | September 24, 2025 (Full Application, by invitation) | November 15, 2025 (Award Notification)
Funding Amounts: Up to $1,000,000 total (direct + indirect) over 2–3 years; indirect costs capped at 10% for nonprofits, none for for-profits
Summary: Supports early-phase (Phase I/II) clinical trials of novel or repurposed therapies for Alzheimer’s disease and related dementias, aiming to accelerate translation to larger efficacy studies.
Key Information: Open internationally to nonprofits and small for-profits; postdoctoral candidates not eligible; LOI required for full application invitation.